About Webster Capital

News

PHARMALOGIC CONTINUES EXPANSION WITH RADIOPHARMACY OF PADUCAH ACQUISITION

Waltham, MA (February 28, 2017) - PharmaLogic, a portfolio company of Webster Capital and leading independent nuclear pharmacy operator, announced today that it has acquired Radiopharmacy of Paducah, which services healthcare markets in Paducah, Kentucky and surrounding geographies. PharmaLogic has expanded into 15 states and represents the fourth largest radiopharmacy group in the United States.

"As PharmaLogic grows, we’ll continue to join forces with companies as dedicated to delivering exceptional products as we are,” said Steve Chilinski, PharmaLogic’s President and CEO. “We look forward to working closely with the excellent professionals at Radiopharmacy of Paducah who have built the company into the respected provider that it is today."

Radiopharmacy of Paducah operates a radiopharmacy that is staffed with nuclear pharmacists and distributes a full range of compounded radioisotopes to hospitals and clinics, primarily for diagnostic nuclear imaging. "We are excited to partner with Radiopharmacy of Paducah as they complement PharmaLogic’s already strong presence in the Midwest corridor," said David Malm, Co-Managing Partner and Head of Healthcare Services at Webster Capital.

About Webster Capital
Founded in 2003, Webster Capital is a private equity partnership which helps companies unlock their potential. Webster focuses on branded consumer and healthcare services companies with EBITDA between $3 million to $15 million. Webster Capital provides equity financing, expertise, and a broad contact network for management buyouts and growth capital. Webster has raised over $600 million of capital and is currently investing Fund III, a $400 million fund raised in 2014. For additional information on Webster Capital, please visit www.webstercapital.com.

About MedEquity Capital
MedEquity Capital is a healthcare private equity firm that focuses on investing in profitable healthcare services, distribution and products companies. Since MedEquity was founded 18 years ago, it has invested just under $300 million of capital with a realized annual rate of return over 20%. For more information, please visit www.medequity.com.

About PharmaLogic
PharmaLogic, a Webster portfolio company, is a group of 16 radiopharmacy locations servicing over 200 hospitals and medical clinics across the United States. For additional information on PharmaLogic, please visit www.pharmalogic.info.

back

©2015 Webster Capital. All rights reserved.